KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Operating Margin: 2010-2025

Historic Operating Margin for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -252.70%.

  • Novavax's Operating Margin fell 9413.00% to -252.70% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.74%, marking a year-over-year increase of 6479.00%. This contributed to the annual value of -36.49% for FY2024, which is 2110.00% up from last year.
  • Latest data reveals that Novavax reported Operating Margin of -252.70% as of Q3 2025, which was down 537.55% from 57.75% recorded in Q2 2025.
  • Novavax's 5-year Operating Margin high stood at 77.33% for Q1 2025, and its period low was -386.37% during Q1 2023.
  • For the 3-year period, Novavax's Operating Margin averaged around -94.88%, with its median value being -67.19% (2023).
  • As far as peak fluctuations go, Novavax's Operating Margin soared by 63,138bps in 2021, and later tumbled by 41,610bps in 2023.
  • Novavax's Operating Margin (Quarterly) stood at -371.27% in 2021, then soared by 30,304bps to -68.24% in 2022, then skyrocketed by 523bps to -63.01% in 2023, then plummeted by 8,542bps to -148.43% in 2024, then crashed by 9,413bps to -252.70% in 2025.
  • Its Operating Margin stands at -252.70% for Q3 2025, versus 57.75% for Q2 2025 and 77.33% for Q1 2025.